First Drug to Delay Type 1 Diabetes Onset Available on NHS

A groundbreaking immunotherapy drug, Teplizumab, is now accessible through the NHS in England and Wales, offering a significant advancement in the management of type 1 diabetes. This treatment is the first of its kind capable of delaying the onset of the disease, potentially giving individuals up to three extra years before symptoms manifest and lifelong insulin dependency begins.

“

The first drug that can delay the onset of type 1 diabetes is being made available on the NHS in England and Wales.

The NHS medicines body has described the decision to make Teplizumab available as "genuinely exciting," anticipating that hundreds of children and young people will benefit annually. Type 1 diabetes, an autoimmune condition where the body's immune system attacks insulin-producing cells in the pancreas, can develop at any age, though it most commonly appears in early adolescence.

Patient advocacy groups have hailed the drug's availability as "momentous" following decades of dedicated work to bring it to fruition. "If it were your child or someone you love, you would want to do everything possible to give them more years without the daily burden of managing this relentless condition," stated Karen Addington, chief executive of the charity Breakthrough T1D. "We now have a treatment that can help make that possible."

“

The NHS medicines body described its decision as 'genuinely exciting', with hundreds of children and young people likely to benefit each year.

Type 1 diabetes requires constant monitoring of blood glucose levels and administration of insulin via injections or a pump. The condition differs from type 2 diabetes, which is often linked to being overweight. For families like the Sebastian-Jennings, whose eight-year-old son Theo was diagnosed at age four, the prospect of delaying the onset is invaluable. "It's something which you can never switch off from," Theo's mother, Vicky, explained, detailing the meticulous carbohydrate counting required for meals. His father, Ben, added, "It would be huge for any family to have those three years of childhood back without the worry and the things he's had to deal with."

“

If it were your child or someone you love, you would want to do everything possible to give them more years without the daily burden of managing this relentless condition.

Teplizumab is administered as an infusion before symptoms appear, requiring an initial blood test to confirm the immune system's attack on the pancreas. This preventative approach marks a significant shift in managing type 1 diabetes, offering a future with potentially less immediate burden for affected children and their families.

“

We now have a treatment that can help make that possible.